Procedures
Kate Tatham, Kinesh Patel in Complete OSCE Skills for Medical and Surgical Finals, 2018
Drug prescription charts vary from hospital to hospital. The following is a guide to what will be required on the front of most charts.The patient’s name, date of birth and hospital number, which must be printed on the drug chart. A printed hospital sticker is sometimes sufficientThe patient’s weight - noting if actual or estimatedThe number of drug charts in total for a patient, and the number of a particular chart within that total (e.g. ‘II of III’ for the second chart in a set of three)The ward on which the patient is basedThe name or initials of the consultant under whose care the patient isDrugs to which the patient is allergic and the reaction that results if the patient is exposed (e.g. erythromycin - nausea and vomiting). This is often required to be visible on each page of the prescription chartThe date the chart was created
Challenges Facing the American Healthcare System
Kant Patel, Mark Rushefsky in Healthcare Politics and Policy in America, 2019
Specialty pharmacies, in order to offer a full range of clinical and operational services that enhance the safety, quality, and affordability of specialty medications for patients, perform a variety of management functions. They include providing access to specially trained pharmacists, nurses, and clinicians, direct consultation with physicians to deal with concerns about side effects of specialty drugs on patients including adverse reaction and non-compliance, performing disease and drug-specific patient care management services to ensure patient safety, collecting data and tracking outcomes for specific patients, ensuring that patients adhere to drug prescription regimens, ensuring adherence to rigorous storage, shipping, and handling standards for specialty drugs, coordinating patient care with other healthcare providers, navigating on behalf of patients with insurance companies, managing formularies, i.e., continually updating lists of prescription drugs approved for reimbursement by PBMs, utilization management such as prior-authorization and quantity limits, encouraging use of preferred products by patients, and cost management (Academy of Managed Care Pharmacy 2006; National Pharmaceutical Services 2018; Pharmaceutical Care Management Association 2016).
Introduction to the management station
Sukhpreet Singh Dubb in Core Surgical Training Interviews, 2020
This is a potentially serious clinical incident that has put the patient at risk, since they are not receiving the advised treatment. I would clarify the events and ensure I was reading the correct patient’s drug chart and that I had understood the changes that had been made to the prescription. I would read the patient’s notes to see if there was any documentation from any member of the team looking after the patient that may explain the circumstances. I would also seek to speak to the nursing staff, especially the nurse who had allegedly changed the drug prescription, and confirm this was how the prescription had been changed. Once I had clarified the situation, I would then ensure the patient was safe and attend to him/her first. I would make any safe changes to rectify their treatment plan and review their progress. Finally, I would document this incident in the notes and seek to escalate the incident by informing a senior member of the team and on-call line at the earliest opportunity.
Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study
Published in Expert Opinion on Drug Safety, 2021
Hye-Rim Kang, Suk-Chan Jang, Ju-Young Shin
The Korean National Health Insurance program began in 1977 and covers the Korean general population since 1989 [14]. Accordingly, the sample cohort data included unidentifiable codes representing each patient. Comprehensive data were collected on various factors, such as demographics including sex, age group recorded at 5-year intervals, income level, and date of death. This database also contains data on healthcare resource utilization, which includes diagnoses, medical procedures, costs, and prescribed drugs. Drug prescription information includes the generic name of the drug, prescription date, duration, and route of administration. The diagnostic codes for specific conditions had been identified according to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).
Continuing trends in U.S. brand-name and generic drug competition
Published in Journal of Medical Economics, 2021
Henry Grabowski, Genia Long, Richard Mortimer, Mehmet Bilginsoy
Following the passage of the Hatch–Waxman Act, the use of generic drugs has increased steadily, with generic products’ share of total prescriptions in the U.S. increasing from 36 percent in 1994 to 90 percent in 20192. Reasons for the increase include the broad adoption by payers of plan provisions that encourage generic drug use, including tiered formularies that have lower patient out-of-pocket costs for generic drugs than for brand-name drugs, step therapy and prior authorization requirements, and formularies that exclude branded drugs and limit formulary coverage to generic drugs in certain therapeutic categories. Automatic state generic substitution laws, which allow pharmacists to substitute generic drugs for brand-name drugs, so long as physicians have not specified that the brand-name drug prescription must be “dispensed as written” have also been key factors in the increased use of generic drugs3,4.
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning
Published in Gynecological Endocrinology, 2020
Giovanni Grandi, Riccardo De Fata, Federico Varliero, Maria Chiara Del Savio, Fabio Facchinetti
The major limitation is the observational design, reporting only medical prescriptions in a certain period of time and in a single center. The included subjects have been further reduced because we wanted to highlight the prescription choices regardless of the MEC guidelines. However, medical prescriptions of contraceptives in our study reflect a choice that is neither only of the doctor nor only of the patient, but a process of shared decision-making [26]. There is only a short follow-up of these patients (3 months) that can show their actual use but not the real satisfaction with the prescribed method: however, the medical prescription choice already represents an important issue worthy of scientific evaluation. Other possible limitations include the non-availability of other basal features, such as body mass index, the objective evaluation of bleeding patterns which can influence decision-making and the US-based (not histological) diagnosis of uterine diseases.
Related Knowledge Centers
- Physician
- Pharmacist
- Prescription Drug
- Over-The-Counter Drug
- Compounding
- Drug Labelling
- Signature
- Generic Drug
- Drug
- Catastrophic Illness